EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,021,000 | -22.3% | 252,972 | -15.3% | 0.00% | -20.0% |
| Q2 2023 | $2,600,000 | +196.1% | 298,804 | 0.0% | 0.01% | +150.0% |
| Q1 2023 | $878,000 | -16.1% | 298,804 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,046,000 | -55.8% | 298,804 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $2,364,000 | +0.5% | 298,804 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $2,352,000 | -35.2% | 298,804 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $3,630,000 | -0.7% | 298,804 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $3,657,000 | -33.6% | 298,804 | -43.5% | 0.01% | -46.7% |
| Q3 2021 | $5,506,000 | +15.9% | 528,428 | 0.0% | 0.02% | +7.1% |
| Q2 2021 | $4,750,000 | -11.5% | 528,428 | -0.0% | 0.01% | -17.6% |
| Q1 2021 | $5,369,000 | +54.4% | 528,468 | 0.0% | 0.02% | +21.4% |
| Q4 2020 | $3,477,000 | – | 528,468 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |